Twist Bioscience Corp (TWST) stock
TWSTNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends September 30
Financials through Q3 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 3, 2026Score 13/30237% above fair value
$111.60−2.62 (-2.29%)
Close on Nov 13, 2026Market cap $7.00BP/E –Yield –
Twist Bioscience gross margin
Gross margin is gross profit as a percentage of revenue.
Twist Bioscience's gross margin for the twelve months ending Jun 30, 2026 was 52.0%. For fiscal 2025 it was 50.7%, against 42.6% the year before. The highest annual figure on record is 50.7% in fiscal 2025.
Annual gross margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Sep 30, 2025 | 50.7% | +8.1 |
| FY2024 | Sep 30, 2024 | 42.6% | +6.0 |
| FY2023 | Sep 30, 2023 | 36.6% | −4.8 |
| FY2022 | Sep 30, 2022 | 41.4% | +2.3 |
| FY2021 | Sep 30, 2021 | 39.1% | +7.2 |
| FY2020 | Sep 30, 2020 | 31.8% | +19.1 |
| FY2019 | Sep 30, 2019 | 12.8% | +39.4 |
| FY2018 | Sep 30, 2018 | -26.6% | +96.5 |
| FY2017 | Sep 30, 2017 | -123.1% | – |
Quarterly gross margin
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q3 FY2026CQ2 2026 | Jun 30, 2026 | 52.8% | −0.6 |
| Q2 FY2026CQ1 2026 | Mar 31, 2026 | 51.6% | +2.0 |
| Q1 FY2026CQ4 2025 | Dec 31, 2025 | 52.0% | +3.8 |
| Q4 FY2025CQ3 2025 | Sep 30, 2025 | 51.3% | +6.2 |
| Q3 FY2025CQ2 2025 | Jun 30, 2025 | 53.4% | +10.1 |
| Q2 FY2025CQ1 2025 | Mar 31, 2025 | 49.6% | +8.6 |
| Q1 FY2025CQ4 2024 | Dec 31, 2024 | 48.3% | +7.8 |
| Q4 FY2024CQ3 2024 | Sep 30, 2024 | 45.1% | +8.5 |
| Q3 FY2024CQ2 2024 | Jun 30, 2024 | 43.3% | +8.9 |
| Q2 FY2024CQ1 2024 | Mar 31, 2024 | 41.0% | +10.3 |
| Q1 FY2024CQ4 2023 | Dec 31, 2023 | 40.5% | −5.2 |
| Q4 FY2023CQ3 2023 | Sep 30, 2023 | 36.6% | −8.3 |
| Q3 FY2023CQ2 2023 | Jun 30, 2023 | 34.4% | −10.5 |
| Q2 FY2023CQ1 2023 | Mar 31, 2023 | 30.8% | −7.5 |
| Q1 FY2023CQ4 2022 | Dec 31, 2022 | 45.7% | +10.1 |
| Q4 FY2022CQ3 2022 | Sep 30, 2022 | 44.9% | +4.2 |
| Q3 FY2022CQ2 2022 | Jun 30, 2022 | 44.8% | +4.6 |
| Q2 FY2022CQ1 2022 | Mar 31, 2022 | 38.3% | −0.8 |
| Q1 FY2022CQ4 2021 | Dec 31, 2021 | 35.6% | +0.1 |
| Q4 FY2021CQ3 2021 | Sep 30, 2021 | 40.7% | −5.1 |
| Q3 FY2021CQ2 2021 | Jun 30, 2021 | 40.2% | +17.9 |
| Q2 FY2021CQ1 2021 | Mar 31, 2021 | 39.0% | +9.3 |
| Q1 FY2021CQ4 2020 | Dec 31, 2020 | 35.5% | +15.9 |
| Q4 FY2020CQ3 2020 | Sep 30, 2020 | 45.8% | +24.5 |
| Q3 FY2020CQ2 2020 | Jun 30, 2020 | 22.3% | +6.1 |
| Q2 FY2020CQ1 2020 | Mar 31, 2020 | 29.7% | +16.7 |
| Q1 FY2020CQ4 2019 | Dec 31, 2019 | 19.6% | +22.8 |
| Q4 FY2019CQ3 2019 | Sep 30, 2019 | 21.3% | +29.5 |
| Q3 FY2019CQ2 2019 | Jun 30, 2019 | 16.2% | +30.9 |
| Q2 FY2019CQ1 2019 | Mar 31, 2019 | 13.0% | +44.3 |
| Q1 FY2019CQ4 2018 | Dec 31, 2018 | -3.2% | +70.7 |
| Q4 FY2018CQ3 2018 | Sep 30, 2018 | -8.2% | – |
| Q3 FY2018CQ2 2018 | Jun 30, 2018 | -14.7% | – |
| Q2 FY2018CQ1 2018 | Mar 31, 2018 | -31.3% | – |
| Q1 FY2018CQ4 2017 | Dec 31, 2017 | -73.8% | – |
See a number that looks wrong?